Business Wire (September 29, 2003)
Permanent Link:
http://vlex.com/vid/zymogenetics-serono-initiate-trial-taci-53191498
Id. vLex: VLEX-53191498
Acceda a este documento
y pruebe vLex GRATIS durante 3 días
ZymoGenetics and Serono Initiate Clinical Trial with TACI-Ig.
Business Editors/Health/Medical Writers
SEATTLE & GENEVA--(BUSINESS WIRE)--Sept. 29, 2003 Inhibitor of B-cell Activation Provides Novel Therapeutic Approach to Treat Debilitating Autoimmune Diseases ZymoGenetics, Inc. (Nasdaq:ZGEN) and Serono S.A. (virt-x:SEO) (NYSE:SRA) announced today the initiation of a Phase 1 clinical trial with TACI-Ig. The trial is a single-dose escalation study in healthy volunteers designed to evaluate the safety and pharmac...Try vLex for FREE for 3 days
Access legal information from United States including:
Try vLex without any commitment for 3 days and see why you need it.
3
days of Free Access
If you are already a vLex customer, Access Here